Application of SB225002 in preparation of medicine for treating myocardial infarction and composition for treating myocardial infarction

Abstract

The invention provides application of SB225002 in preparation of a medicine for treating myocardial infarction and a composition for treating myocardial infarction, and relates to the technical field of medicines. The main mechanism of the SB225002 for treating myocardial infarction is inflammation inhibition and myocardial repair and regeneration promotion, and the SB225002 is used for regulating and controlling a group of specific mononuclear cells so as to achieve the effect of inhibiting multiple inflammation signal channels, including reduction of the expression quantity of channel-related genes and the like; meanwhile, the SB225002 can also promote proliferation of myocardial cells and angiogenesis and reduce the fibrosis degree of heart tissue after infarction, so that repair and regeneration of the heart after infarction are promoted; the SB225002 enables inflammation and repair to reach a certain balance, so that a better treatment effect is achieved.

Images